INSIGHT

Commercialization Execution in Complex Markets

Commercialization becomes fundamentally different when market complexity is not an exception, but a defining feature of the environment in which the organization must operate.

By Mónica González – Published February 26, 2026

Market Complexity Changes the Commercialization Challenge

Commercialization strategies are often developed around an expected market environment: stakeholder needs, treatment pathways, access conditions, competitive dynamics, organizational capabilities, and assumptions about how the product will reach patients and customers.

In complex markets, many of those conditions vary significantly. Healthcare systems operate differently, reimbursement pathways can determine what is commercially possible, stakeholder influence may be distributed across multiple decision-makers, infrastructure and capabilities differ, and local regulatory or operational requirements can materially affect execution.

The challenge is therefore not simply implementing a global commercialization strategy in a more difficult environment. It is determining which parts of the strategy remain valid, which need to adapt, and what the organization needs to execute effectively under those specific conditions.

Complexity Is Not the Same in Every Market

Organizations sometimes describe markets as complex as though complexity were a single characteristic. In practice, its sources can be very different.

One market may have a fragmented healthcare system and highly decentralized decision-making. Another may have concentrated purchasing power and difficult access conditions. Some markets require extensive distributor or partner involvement, while others depend heavily on specialist networks, institutional stakeholders, or government relationships. Organizational maturity and internal capabilities may also vary substantially.

These differences matter because they create different execution requirements. A commercialization model designed to address access complexity may not solve capability limitations, while an approach built around direct affiliate execution may be inappropriate where external partners play a critical role.

Understanding the source of complexity is therefore more useful than simply classifying a market as difficult.

Commercialization Models Need to Reflect How the Market Actually Works

Global organizations benefit from consistency. Positioning, strategic priorities, evidence, governance principles, and core commercialization choices should not be reinvented independently in every geography.

But consistency becomes counterproductive when it assumes that execution conditions are also consistent. Commercialization models need to reflect how decisions are made locally, which stakeholders influence adoption, how patients move through the healthcare system, what access barriers exist, which capabilities are available, and how the organization can realistically operate.

This requires more than localizing tactics. In some markets, the operating model itself may need to differ. Capabilities may need to be shared regionally, external partners may perform important activities, governance may require different interfaces, or investment may need to be sequenced differently.

The objective is to preserve strategic coherence while allowing the commercialization model to fit the market rather than forcing the market to fit the model.

Capability Gaps Can Be as Important as Market Opportunity

An attractive commercial opportunity does not necessarily mean an organization is ready to capture it. Complex markets can require capabilities that are not yet present locally or that would be inefficient to build permanently.

Organizations therefore need to assess not only market potential but execution requirements. Which capabilities must exist close to the market? Which can be provided globally or regionally? Which require specialized external expertise? Which need to be built over time?

This can materially affect investment and sequencing. A market with significant potential may require substantial capability development before broader commercialization becomes realistic, while another may be executable through a leaner model using existing regional infrastructure.

Commercial attractiveness and execution readiness need to be considered together.

External Partners Can Become Part of the Commercialization Model

Complex markets frequently involve distributors, commercialization partners, service providers, healthcare institutions, technology providers, or other external organizations. Their role can extend well beyond supplying additional capacity.

Where partners perform activities that materially influence commercialization, organizations need clarity about responsibilities, decisions, information flows, performance expectations, and accountability. Outsourcing an activity does not outsource responsibility for the commercialization outcome.

The relationship also needs sufficient visibility for the organization to understand what is happening in the market. Without it, externalization can create operational distance precisely where local understanding is most important.

A partner model should therefore be designed as part of the commercialization operating model, not treated simply as a contractual arrangement around it.

Governance Needs to Match the Source of Complexity

Complex markets often generate exceptions. Local access conditions challenge global assumptions, partners require decisions, stakeholder developments affect priorities, or investments need to be reconsidered as new information emerges.

Governance needs to make those exceptions manageable without forcing every local decision upward. Markets should understand where they have authority to adapt, which decisions require broader alignment, and when a local issue has consequences significant enough to require regional or global involvement.

The appropriate governance model may therefore differ according to the market and operating model. What matters is that accountability remains clear and consequential decisions can reach the appropriate level quickly enough to influence execution.

Good governance provides control without making local complexity harder to navigate.

Market Learning Should Influence the Commercialization Model

Complex markets rarely behave exactly as anticipated. Stakeholder responses, access developments, partner performance, competitive activity, patient pathways, and operational experience generate information that can challenge assumptions made during planning.

Organizations need to capture that learning and determine what it means. Some findings will be highly local. Others may reveal a weakness in the broader commercialization model or provide an approach that could improve execution elsewhere.

This requires more than performance reporting. Teams need mechanisms for connecting market evidence with the people capable of interpreting its strategic and operational implications.

Over time, commercialization in complex markets should become more informed by execution, not simply more standardized through experience.

AI Can Make Complexity More Manageable

AI can help organizations work with information that is dispersed across markets, stakeholders, functions, partners, and internal knowledge sources. Research, evidence synthesis, market comparison, knowledge retrieval, monitoring, and operational visibility can all become faster and more scalable.

This is particularly valuable in complex markets because leaders can gain a more current understanding of local developments without requiring equivalent growth in reporting and coordination infrastructure. AI can also help identify patterns across markets that might otherwise remain hidden within individual teams.

But complexity is not simply an information problem. Understanding why a stakeholder behaves differently, whether a partner relationship is working, how much local adaptation is appropriate, or whether an access development changes the commercial opportunity still requires context and judgment.

AI can improve the organization’s ability to understand complexity. Experienced people remain responsible for deciding how to act within it. Human-Led. AI-Enabled.

Complex Markets Require Deliberate Commercialization Design

There is no single operating model for commercializing successfully in a complex market. The appropriate approach depends on the healthcare environment, stakeholder structure, access conditions, organizational capabilities, external partners, strategic importance of the market, and the nature of the opportunity itself.

The strongest organizations therefore do not respond to complexity simply by adding resources, processes, or oversight. They understand where the complexity comes from and design execution around it, deciding what should remain globally consistent, what needs local adaptation, which capabilities are required, how partners fit, and where decisions should sit.

Commercialization in complex markets is ultimately an exercise in fit. The strategy needs to remain coherent, but the operating model needs to work in the market that actually exists.